LYMPHOMA, LARGE B-CELL, DIFFUSE

Clinical trials for LYMPHOMA, LARGE B-CELL, DIFFUSE explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, LARGE B-CELL, DIFFUSE trials appear

Sign up with your email to follow new studies for LYMPHOMA, LARGE B-CELL, DIFFUSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 2 Completed 4 Terminated 1

Experimental drug targets tough blood cancers in early safety trial

Disease control Not yet recruiting

This early-stage trial is testing a new drug called LY4152199 in people with B-cell lymphomas that have returned or didn't respond to previous treatments. The main goals are to find a safe dose and see if the drug shows any signs of helping control the cancer. The study will enro…

Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE

Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

LYMPHOMA, LARGE B-CELL, DIFFUSE

Get alerted when new LYMPHOMA, LARGE B-CELL, DIFFUSE trials appear

Experimental drug targets tough blood cancers in early safety trial